ES2011482A6 - Procedimiento de preparacion de una composicion farmaceutica de efectos antinflamatorios, antipireticos y sedantes. - Google Patents

Procedimiento de preparacion de una composicion farmaceutica de efectos antinflamatorios, antipireticos y sedantes.

Info

Publication number
ES2011482A6
ES2011482A6 ES8700548A ES8700548A ES2011482A6 ES 2011482 A6 ES2011482 A6 ES 2011482A6 ES 8700548 A ES8700548 A ES 8700548A ES 8700548 A ES8700548 A ES 8700548A ES 2011482 A6 ES2011482 A6 ES 2011482A6
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
pharmaceutical compositions
inflammatory effect
analgesic
diamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8700548A
Other languages
English (en)
Inventor
Lujza Petocz
Istvan Simonyi
Ivan Beck
Gabor Gigler
Marton Fekete
Eniko Kiszelly
Attila Mandi
Frighyes Gorgenyi
Andras Dietz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES2011482A6 publication Critical patent/ES2011482A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE UNA COMPOSICION FARMACEUTICA DE EFECTOS ANTIINFLAMATORIOS, ANTIPIRETICOS Y SEDANTES. EL PROCEDIMIENTO ESTA CARACTERIZADO PORQUE COMPRENDE LA MEZCLA DE 2,4-DIAMINO-5-(3,4-DIMETOXI-BENCIL)-PIRIMIDINA O UNA SAL DE ADICION ACIDA DE ELLA FARMACEUTICAMENTE ACEPTABLE, CON ADECUADOS VEHICULOS FARMACEUTICOS INERTES SOLIDOS O LIQUIDOS EN LAS PROPORCIONES DE ENTRE 1 A 75% EN PESO Y 99 Y 250% EN PESO RESPECTIVAMENTE, REALIZANDOSE LA REACCION A UNA TEMPERATURA COMPRENDIDA ENTRE LA TEMPERATURA AMBIENTE Y 60GC. LAS COMPOSICIONES FARMACEUTICAS OBTENIDAS MUESTRAN EL DESEADO EFECTO ANALGESICO Y ANTI-INFLAMATORIO SIN CAUSAR INDESEADOS EFECTOS SECUNDARIOS ULCEROGENICOS.
ES8700548A 1986-02-28 1987-02-28 Procedimiento de preparacion de una composicion farmaceutica de efectos antinflamatorios, antipireticos y sedantes. Expired - Lifetime ES2011482A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU86842A HU197670B (en) 1986-02-28 1986-02-28 Process for producing composition comprising 2,4-diamino-5-(3,4-dimethoxybenzyl)-pyrimidine or pharmaceutically suitable acid addition salt thereof as active ingredient

Publications (1)

Publication Number Publication Date
ES2011482A6 true ES2011482A6 (es) 1990-01-16

Family

ID=10951648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8700548A Expired - Lifetime ES2011482A6 (es) 1986-02-28 1987-02-28 Procedimiento de preparacion de una composicion farmaceutica de efectos antinflamatorios, antipireticos y sedantes.

Country Status (14)

Country Link
US (1) US4873249A (es)
JP (1) JPS62265224A (es)
CN (1) CN87100984A (es)
CH (1) CH673584A5 (es)
DE (1) DE3706431A1 (es)
DK (1) DK104287A (es)
ES (1) ES2011482A6 (es)
FI (1) FI870879A (es)
FR (1) FR2595048B1 (es)
GB (1) GB2187094B (es)
HU (1) HU197670B (es)
IT (1) IT1216894B (es)
NL (1) NL8700501A (es)
SE (1) SE8700829L (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144555C (da) * 1978-10-26 1982-11-01 Gram Broedrene A S Fremgangsmaade til brug ved emballering af genstande i et antal emballagematerialebaner og apparat til brug ved udoevelse affremgangsmaaden

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE2343419A1 (de) * 1973-08-29 1975-03-13 Gruenenthal Chemie Verfahren zur herstellung von pyrimidinderivaten
GB1466048A (en) * 1974-08-14 1977-03-02 Sankyo Co Method of controlling coccidiosis and compositions and compounds useful therefor
JPS55102517A (en) * 1979-01-30 1980-08-05 Shionogi & Co Ltd Preparation of sulfamethoxazole-trimethoprim complex for administration via body cavity
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
GB2116962A (en) * 1982-03-18 1983-10-05 Ciba Geigy Ag Nitriles; pyrimidines

Also Published As

Publication number Publication date
GB8704660D0 (en) 1987-04-01
IT1216894B (it) 1990-03-14
HUT43491A (en) 1987-11-30
FR2595048A1 (fr) 1987-09-04
FI870879A0 (fi) 1987-02-27
CN87100984A (zh) 1988-02-24
HU197670B (en) 1989-05-29
SE8700829L (sv) 1987-08-29
CH673584A5 (es) 1990-03-30
SE8700829D0 (sv) 1987-02-27
NL8700501A (nl) 1987-09-16
DK104287A (da) 1987-08-29
JPS62265224A (ja) 1987-11-18
FR2595048B1 (fr) 1990-07-13
DE3706431A1 (de) 1987-10-01
DE3706431C2 (es) 1990-05-17
DK104287D0 (da) 1987-02-27
GB2187094A (en) 1987-09-03
US4873249A (en) 1989-10-10
IT8719512A0 (it) 1987-02-27
GB2187094B (en) 1990-02-21
FI870879A (fi) 1987-08-29

Similar Documents

Publication Publication Date Title
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
AU585495B2 (en) Pharmaceutical composition for the treatment of acute myocardial ischemia
JO1502B1 (en) New pharmacy vehicles
MY115339A (en) Compositions containing micronized nebivolol
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
MY101784A (en) Novel pharmacological compounds
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
GR852395B (es)
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IL105276A (en) (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
GEP19991869B (en) Amino Acid Derivatives of Substituted Quinoxaline 2,3-Dione Derivatives as Glutamate Receptor Antagonists
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
ES2011482A6 (es) Procedimiento de preparacion de una composicion farmaceutica de efectos antinflamatorios, antipireticos y sedantes.
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
ES469020A1 (es) Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-02-28

FD1A Patent lapsed

Effective date: 19990405